F3V-29989-39204
2 vaccinations
7 coded responses
16 check-ins
7 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 770 / TX
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Registered in v-safe
-
2021-04-09
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-09
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-11
- 2021-04-12
-
2021-04-13
Survey response — days 1–6 daily, dose 1MedDRA: Decreased appetite — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: No appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessFree text: Site of injection is very tender to touch.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Health check-in — day 7, dose 1Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-04-23
-
2021-05-01
Survey response — day 21, single doseMedDRA: Chest pain, Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: CoughCongestionRunny noseBurning in chestMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Report sent to call center — day 21, single doseBe unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-07
Survey response — day 28, single doseMedDRA: Fluid retention, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Fluid retention in my lower legs. Doctors appointment has been scheduled. No previous health issues. · Healthcare visit (other): Appointment scheduledMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-07
Report sent to call center — day 28, single doseGet care from a doctor or other healthcare professional1 call case(s)
- 2021-05-16
-
2021-05-23
Survey response — day 42, single doseMedDRA: Cough — Feeling: GoodFree text: CoughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-27
- 2021-07-09
-
2021-10-08
Survey response — 6 months, dose 1MedDRA: COVID-19, Fluid retention, Migraine — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Retaining fluid with no underlying conditions. Diagnosed with Covid migrainesMedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Report sent to call center — 6 months, dose 1Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-11
- 2021-10-15
- 2022-04-09
-
2022-04-10
Dose 2 — Moderna
- 2022-07-11
-
2022-10-09
Survey response — 6 months, dose 2MedDRA: Dyspnoea, Fluid retention, Heart rate increased — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Water retention, shortness of breath and accelerated heartbeats which has been classified as a side effect from covidMedDRA releases: 2024-11 · check-in free text available
-
2022-10-09
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-10-10
- 2022-10-10
- 2022-10-10
- 2022-10-10
-
2022-10-19
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-19
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-19
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-19
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Janssen/Johnson & Johnson | |
| 2 | 2022-04-10 | Moderna | No |
Call center
4 call center cases
4 successful
1 wait over 3 months for a first call
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): No appetite
Systemic reaction (other): Site of injection is very tender to touch.
Release 8 — day 21, single dose
Symptoms: CoughCongestionRunny noseBurning in chest
Release 8 — day 28, single dose
Symptoms: Fluid retention in my lower legs. Doctors appointment has been scheduled. No previous health issues.
Healthcare visit (other): Appointment scheduled
Release 8 — day 42, single dose
Symptoms: Cough
Release 10 — 6 months, dose 1
Symptoms: Retaining fluid with no underlying conditions. Diagnosed with Covid migraines
Release 12 — 6 months, dose 2
Symptoms: Water retention, shortness of breath and accelerated heartbeats which has been classified as a side effect from covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fluid retention | ✓ | ✓ | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release